News

Swiss biopharmaceutical company Actelion has reported that the Independent Data and Safety Monitoring Board or DSMB has recommended continuation of the pivotal Phase III study BUILD-3, evaluating the

Entellus Medical, a medical technology company, has started enrollment in the FinESS Registry, a prospective, post-approval registry study designed to assess subject rhinosinusitis symptomatic status of up to

US-based Sadra Medical, a developer of new therapies for the treatment of aortic valve disease, has raised $30m in new investment capital. The round was led by Accuitive

In his position at SRI, he also developed technologies for vibration and acoustic control of large-scale systems. “We are pleased to add Gary Guthart to the company’s board,”

Amsterdam Molecular Therapeutics or AMT, a Netherlands-based company engaged in the development of human gene therapy, has initiated treatment of the first patient in a preregistration clinical trial

Canadian biopharmaceutical company Tekmira Pharmaceuticals has reported that its investigational new drug or IND application for ApoB SNALP has received clearance from the FDA allowing it to begin

AVI BioPharma, a developer of RNA-based drugs, has obtained a $2.5m contract from Children’s National Medical Center or CNMC in Washington, District of Columbia, to support preclinical studies

Oxygen Biotherapeutics, a company engaged in the business of developing biotechnology products with a focus on oxygen delivery to tissue, has filed an application with the FDA to

Wyeth Pharmaceuticals, a division of Wyeth, has reported that FDA has granted priority review to the company’s biologic license application or BLA for Prevnar 13, a Pneumococcal 13-valent